Company Overview
- Headquarters
- Perryville III Corporate Park 53 Frontage Roa, Hampton NJ
- Website
- ikaria.cat
- Phone
- (908) 238-6600
- Employees
- 36
- Founded in
- 2007
- Industry
- Materials/Manufacturing
- NAICS Code
-
NAICS Code 325 CompaniesNAICS Code 33 CompaniesNAICS Code 339 CompaniesNAICS Code 32 CompaniesNAICS Code 3254 Companies
- SIC Code
-
SIC Code 38 CompaniesSIC Code 384 Companies
Financials & Stats
Revenue
$58B
Who is IKAR
Ikaria, Inc. is a privately held critical care company based in Hampton, New Jersey. The company has a workforce of 36 employees and generated $57.7 million in revenue. Ikaria focuses on developing and commercializing innovative therapies, including drugs and devices, to address the unique needs of critically ill patients. Their flagship product is INOMAX® (nitric oxide) for inhalation, an FDA-approved drug for treating hypoxic respiratory failure in infants with pulmonary hypertension. The INOMAX therapy package, which comprises the drug product, drug-delivery system, on-site training, and round-the-clock technical assistance, is marketed in several countries including the USA, Puerto Rico, Canada, Australia, Mexico, and Japan. For more information about Ikaria and their innovative therapies, visit their website at ikaria.cat.
Company Leadership
IKAR Industry Tags
Companies Similar to IKAR
Analyze industry trends and opportunities by examining competitors and companies comparable to IKAR, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 58M | 77 | Earth City, MO | 2004 | |
| 57M | 150 | Boise, ID | 1994 | |
| 57M | 100 | Clifton, NJ | 1911 | |
| 56M | 35 | Reedsburg, WI | 1920 | |
| 56M | 186 | Oxford, CT | 1953 |